Cargando…
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796571/ http://dx.doi.org/10.1186/1471-2407-7-S1-A27 |
_version_ | 1782132232492679168 |
---|---|
author | Candelaria, Myrna Gallardo-Rincón, Dolores Arce, Claudia Cetina, Lucely Aguilar-Ponce, Jose Luis Arrieta, Oscar Serrano, Alberto Perez-Plasencia, Carlos Gonzalez-Fierro, Aurora de la Cruz-Hernandez, Erik Revilla-Vazquez, Alma Chavez-Blanco, Alma Trejo-Becerril, Catalina Perez-Cardenas, Enrique Taja-Chayeb, Lucia Camargo, Maria F Robles, Elizabeth Dueñas-Gonzalez, Alfonso |
author_facet | Candelaria, Myrna Gallardo-Rincón, Dolores Arce, Claudia Cetina, Lucely Aguilar-Ponce, Jose Luis Arrieta, Oscar Serrano, Alberto Perez-Plasencia, Carlos Gonzalez-Fierro, Aurora de la Cruz-Hernandez, Erik Revilla-Vazquez, Alma Chavez-Blanco, Alma Trejo-Becerril, Catalina Perez-Cardenas, Enrique Taja-Chayeb, Lucia Camargo, Maria F Robles, Elizabeth Dueñas-Gonzalez, Alfonso |
author_sort | Candelaria, Myrna |
collection | PubMed |
description | |
format | Text |
id | pubmed-1796571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-17965712007-02-09 A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors Candelaria, Myrna Gallardo-Rincón, Dolores Arce, Claudia Cetina, Lucely Aguilar-Ponce, Jose Luis Arrieta, Oscar Serrano, Alberto Perez-Plasencia, Carlos Gonzalez-Fierro, Aurora de la Cruz-Hernandez, Erik Revilla-Vazquez, Alma Chavez-Blanco, Alma Trejo-Becerril, Catalina Perez-Cardenas, Enrique Taja-Chayeb, Lucia Camargo, Maria F Robles, Elizabeth Dueñas-Gonzalez, Alfonso BMC Cancer Meeting Abstract BioMed Central 2007-02-05 /pmc/articles/PMC1796571/ http://dx.doi.org/10.1186/1471-2407-7-S1-A27 Text en Copyright © 2007 Candelaria et al; licensee BioMed Central Ltd. |
spellingShingle | Meeting Abstract Candelaria, Myrna Gallardo-Rincón, Dolores Arce, Claudia Cetina, Lucely Aguilar-Ponce, Jose Luis Arrieta, Oscar Serrano, Alberto Perez-Plasencia, Carlos Gonzalez-Fierro, Aurora de la Cruz-Hernandez, Erik Revilla-Vazquez, Alma Chavez-Blanco, Alma Trejo-Becerril, Catalina Perez-Cardenas, Enrique Taja-Chayeb, Lucia Camargo, Maria F Robles, Elizabeth Dueñas-Gonzalez, Alfonso A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title_full | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title_fullStr | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title_full_unstemmed | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title_short | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
title_sort | phase ii study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796571/ http://dx.doi.org/10.1186/1471-2407-7-S1-A27 |
work_keys_str_mv | AT candelariamyrna aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT gallardorincondolores aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT arceclaudia aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT cetinalucely aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT aguilarponcejoseluis aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT arrietaoscar aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT serranoalberto aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT perezplasenciacarlos aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT gonzalezfierroaurora aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT delacruzhernandezerik aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT revillavazquezalma aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT chavezblancoalma aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT trejobecerrilcatalina aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT perezcardenasenrique aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT tajachayeblucia aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT camargomariaf aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT robleselizabeth aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT duenasgonzalezalfonso aphaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT candelariamyrna phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT gallardorincondolores phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT arceclaudia phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT cetinalucely phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT aguilarponcejoseluis phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT arrietaoscar phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT serranoalberto phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT perezplasenciacarlos phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT gonzalezfierroaurora phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT delacruzhernandezerik phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT revillavazquezalma phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT chavezblancoalma phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT trejobecerrilcatalina phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT perezcardenasenrique phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT tajachayeblucia phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT camargomariaf phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT robleselizabeth phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors AT duenasgonzalezalfonso phaseiistudyofepigenetictherapywithhydralazineandmagnesiumvalproatetoovercomechemotherapyresistanceinrefractorysolidtumors |